Monitoring therapeutic monoclonal antibodies in brain tumor

Top Down proteomics: Facts and perspectives

(2014) Adam D. Catherman et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Antibodies to watch in 2014

(2014) Janice M Reichert   mAbs

Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry

(2014) Sara Rosati et al.   Nature Protocols

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

(2014) Olivier L. Chinot et al.   NEW ENGLAND JOURNAL OF MEDICINE

Selected Protein Monitoring in Histological Sections by Targeted MALDI-FTICR In-Source Decay Imaging

(2013) David Calligaris et al.   ANALYTICAL CHEMISTRY

Emerging antiangiogenics for renal cancer

(2013) Charlotte Domblides et al.   EXPERT OPINION ON EMERGING DRUGS

Protein Digestion: An Overview of the Available Techniques and Recent Developments

(2013) Linda Switzar et al.   JOURNAL OF PROTEOME RESEARCH

Characterization of Therapeutic Antibodies and Related Products

(2012) Alain Beck et al.   ANALYTICAL CHEMISTRY

Importance and Limitations of Chemotherapy Among the Available Treatments for Gastrointestinal Tumours

(2012) Jose Marin et al.   Anti-Cancer Agents in Medicinal Chemistry

Tubulin isoforms identified in the brain by MALDI in-source decay

(2012) Rima Ait-Belkacem et al.   Journal of Proteomics

Mass spectrometry imaging is moving toward drug protein co-localization

(2012) Rima Ait-Belkacem et al.   TRENDS IN BIOTECHNOLOGY

A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies

(2012) Sabrina Oliveira et al.   EJNMMI Research

Matrix Sublimation/Recrystallization for Imaging Proteins by Mass Spectrometry at High Spatial Resolution

(2011) Junhai Yang et al.   ANALYTICAL CHEMISTRY

N-terminal Glutamate to Pyroglutamate Conversionin Vivofor Human IgG2 Antibodies

(2011) Y. Diana Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Advances in top-down proteomics for disease biomarker discovery

(2011) David Calligaris et al.   Journal of Proteomics

Monoclonal antibodies in neuro-oncology

(2011) Lois A. Lampson   mAbs

Discrimination of Isobaric Leucine and Isoleucine Residues and Analysis of Post-Translational Modifications in Peptides by MALDI In-Source Decay Mass Spectrometry Combined with Collisional Cooling

(2010) Jens Soltwisch et al.   ANALYTICAL CHEMISTRY

MALDI-In Source Decay Applied to Mass Spectrometry Imaging: A New Tool for Protein Identification

(2010) Delphine Debois et al.   ANALYTICAL CHEMISTRY

Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections

(2010) R. Nau et al.   CLINICAL MICROBIOLOGY REVIEWS

Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit Fusion

(2010) K. Huang et al.   JOURNAL OF VIROLOGY

The VEGF family in cancer and antibody-based strategies for their inhibition

(2010) Laura A. Sullivan et al.   mAbs

Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry

(2010) Anna Nilsson et al.   PLoS One

To protect peptide pharmaceuticals against peptidases

(2010) R. Rink et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Bevacizumab: current indications and future development for management of solid tumors

(2009) Jenia Jenab-Wolcott et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

(2009) Henry S. Friedman et al.   JOURNAL OF CLINICAL ONCOLOGY

Imaging mass spectrometry for the assessment of drugs and metabolites in tissue

(2009) Paul J Trim et al.   Bioanalysis

A History of Cancer Chemotherapy

(2008) Vincent T. DeVita et al.   CANCER RESEARCH